RWE: Relevance, Reporting, and AI

Join Rob Matheis and Richard White for a discussion of the basics of what Real World Evidence (RWE) is and how it is different from HEOR, to the big questions of how the global use of RWE has changed over time and how the rise of AI - both analytics and large language models - could change the landscape of RWE. What changes should medical communications professionals be aware of in the reporting and usage of RWE data?

Richard White is the Chief Operating Officer of Oxford PharmaGenesis, a global, independent HealthScience communications consultancy. He has more than 20 years of experience in Medical Affairs, and founded the Oxford PharmaGenesis Value Demonstration and Patient Engagement Practices to apply evidence-based communication best practice to clinical, HEOR, RWE, patient-reported outcome (PRO) and patient preference studies. He has run training workshops in these areas for multiple pharmaceutical companies, and has also delivered invited presentations, panel discussions and roundtables at international conferences such as ISMPP, TIPPA, Patient Summit Europe, Patient Engagement & Experience Summit and the World Orphan Drug Congress.